keyword
MENU ▼
Read by QxMD icon Read
search

ovarios cancer

keyword
https://www.readbyqxmd.com/read/27448503/ovario-protective-effects-of-genistein-against-cyclophosphamide-toxicity-in-rats-role-of-anti-m%C3%A3-llerian-hormone-and-oestradiol
#1
Dalia O Saleh, Dina F Mansour
Cyclophosphamide (CP), the commonly used chemotherapeutic agent in cancer treatment, is proven to cause ovarian toxicity and infertility in women. In the present study, we investigated the protective effect of genistein (GEN), a phytoestrogen found in the soy protein, against CP-induced ovarian toxicity in rats. Forty female adult rats were allocated into five groups. A normal control group received the vehicle; another group was injected with a single acute intraperitoneal dose of CP (200mg/kg). Three other groups were pretreated with GEN (0...
October 15, 2016: European Journal of Pharmacology
https://www.readbyqxmd.com/read/26304156/randomized-study-of-sequential-cisplatin-topotecan-carboplatin-paclitaxel-versus-carboplatin-paclitaxel-effects-on-quality-of-life
#2
RANDOMIZED CONTROLLED TRIAL
Lori Brotto, Michael Brundage, Paul Hoskins, Ignace Vergote, Andres Cervantes, Herraez A Casado, A Poveda, Elizabeth Eisenhauer, Dongsheng Tu
BACKGROUND: A recent phase III trial compared the efficacy of cisplatin-topotecan (a topoisomerase I inhibitor) followed by carboplatin-paclitaxel (Arm 1) versus paclitaxel-carboplatin (Arm 2) in women with newly diagnosed stage IIB or greater ovarian cancer. There was a significantly lower response rate in the experimental arm compared to standard treatment, and less likelihood of normalized CA125 within the first 3 months. At 43 months follow-up, there were no significant group differences in progression-free survival...
March 2016: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/23650680/-third-national-ovarian-consensus-2011-grupo-de-investigaci%C3%A3-n-en-c%C3%A3-ncer-de-ovario-y-tumores-ginecol%C3%A3-gicos-de-m%C3%A3-xico-gicom
#3
Dolores Gallardo-Rincón, David Cantú-de-León, Patricia Alanís-López, Miguel Angel Alvarez-Avitia, Joel Bañuelos-Flores, Guillermo Sidney Herbert-Núñez, Luis Fernando Oñate-Ocaña, María Delia Pérez-Montiel, Amelia Rodríguez-Trejo, Eva Ruvalcaba-Limón, Alberto Serrano-Olvera, Andrea Ortega-Rojo, Patricia Cortés-Esteban, Aura Erazo-Valle, Raquel Gerson-Cwilich, Jaime De-la-Garza-Salazar, Dan Green-Renner, Eucario León-Rodríguez, Flavia Morales-Vásquez, Andrés Poveda-Velasco, José Luis Aguilar-Ponce, Luis Felipe Alva-López, Salvador Alvarado-Aguilar, Isabel Alvarado-Cabrero, Cinthia Alejandra Aquino-Mendoza, Carlos Eduardo Aranda-Flores, Artfy Bandera-Delgado, Eduardo Barragán-Curiel, Patricia Barrón-Rodríguez, Rocío Brom-Valladares, Paula Anel Cabrera-Galeana, Germán Calderillo-Ruiz, Salvador Camacho-Gutiérrez, Daniel Capdeville-García, Jesús Cárdenas-Sánchez, Elisa Carlón-Zárate, Oscar Carrillo-Garibaldi, Gerardo Castorena-Roji, Guadalupe Cervantes-Sánchez, Jaime Alberto Coronel-Martínez, José Gregorio Chanona-Vilchis, Verónica Díaz-Hernández, Pedro Escudero-de-los Ríos, Olga Garibay-Cerdenares, Eva Gómez-García, Luis Alonso Herrera-Montalvo, Luz María Hinojosa-García, David Isla-Ortiz, Josefina Jiménez-López, Arturo Javier Lavín-Lozano, Jesús Alberto Limón-Rodriguez, Horacio Noé López-Basave, Sergio César López-García, Antonio Maffuz-Aziz, Jorge Martínez-Cedillo, Dulce María Martínez-López, Juan Manuel Medina-Castro, Carlos Melo-Martínez, Carmen Méndez-Herrera, Gonzalo Montalvo-Esquivel, Miguel Angel Morales-Palomares, Andrés Morán-Mendoza, Gilberto Morgan-Villela, Aída Mota-García, David Eduardo Muñoz-González, Francisco J Ochoa-Carrillo, Maricruz Pérez-Amador, Edgar Recinos-Money, Samuel Rivera-Rivera, Juan U Robles Flores, Edith Rojas-Castillo, Carlos Rojas-Marín, Efraín Salas-Gonzáles, Liliana Sámano-Nateras, Miguel Santibañez-Andrade, Antonio Santillán-Gómez, Araceli Silva-García, Juan Alejandro Silva, Gilberto Solorza-Luna, Adán Raúl Tabarez-Ortiz, Patricia Talamás-Rohana, Laura Leticia Tirado-Gómez, Alfonso Torres-Lobatón, Félix Quijano-Castro
INTRODUCTION: Ovarian cancer (OC) is the third most common gynecologic malignancy worldwide. Most of cases it is of epithelial origin. At the present time there is not a standardized screening method, which makes difficult the early diagnosis. The 5-year survival is 90% for early stages, however most cases present at advanced stages, which have a 5-year survival of only 5-20%. GICOM collaborative group, under the auspice of different institutions, have made the following consensus in order to make recommendations for the diagnosis and management regarding to this neoplasia...
November 2011: Revista de Investigación Clínica; Organo del Hospital de Enfermedades de la Nutrición
https://www.readbyqxmd.com/read/21416918/-the-first-mexican-consensus-of-endometrial-cancer-grupo-de-investigaci%C3%A3-n-en-c%C3%A3-ncer-de-ovario-y-tumores-ginecol%C3%A3-gicos-de-m%C3%A3-xico
#4
Eva Ruvalcaba-Limón, David Cantú-de-León, Eucario León-Rodríguez, Patricia Cortés-Esteban, Alberto Serrano-Olvera, Flavia Morales-Vásquez, Ricardo Sosa-Sánchez, Andrés Poveda-Velasco, Alejandro Crismatt-Zapata, Antonio Santillán-Gómez, Carmen Aguilar-Jiménez, Patricia Alanís-López, Paulino Alfaro-Ramírez, Miguel Angel Alvarez-Avitia, Carlos Eduardo Aranda-Flores, José Héctor Reynaldo Arias-Ceballos, Oscar Arrieta-Rodríguez, Eduardo Barragán-Curiel, Daniel Botello-Hernández, Rocío Brom-Valladares, Paula Anel Cabrera-Galeana, Juan Carlos Cantón-Romero, Daniel Capdeville-García, Jesús Cárdenas-Sánchez, Gerardo Castorena-Roji, Friedman Rafael Cepeda-López, Guadalupe Cervantes-Sánchez, Lucely de Carmen Cetina-Pérez, Jaime Alberto Coronel-Martínez, Seir Alfonso Cortés-Cárdenas, Juan Carlos Cruz-López, Jaime G de la Garza-Salazar, Consuelo Díaz-Romero, Alfonso Dueñas-González, Aura Erazo Valle-Solís, Pedro Escudero-de los Ríos, Efrén Flores-Alvarez, Rolando García-Matus, Raquel Gerson-Cwilich, Aarón González-Enciso, César González-de-León, Alfonso Genaro Guevara-Torres, Guillermo Sidney Herbert-Núñez, Carlos Hernández-Hernández, Dulce María Hernández-Hernández, David Isla-Ortiz, Ramiro Jesús-Sandoval, Carlos Jiménez-Cervantes, Roberto Kuri-Exsome, José Luis López-Obispo, Antonio Maffuz-Aziz, Luis Manuel Martínez-Barrera, Juan Manuel Medina-Castro, Gonzalo Montalvo-Esquivel, Víctor Hugo Mora-Aguilar, Miguel Angel Morales-Palomares, Andrés Morán-Mendoza, Gilberto Morgan-Villela, Aída Mota-García, David Eduardo Muñoz-González, Dino Alberto Murillo-Cruz, Arturo Novoa-Vargas, Francisco J Ochoa-Carrillo, Luis Fernando Oñate-Ocaña, Andrea Ortega-Rojo, Alma Georgina Palacios-Martínez, Antonio Palomeque-López, María Delia Pérez-Montiel, Félix Quijano-Castro, Samuel Rivera-Rivera, Lesbia María Rivera-Rubí, Juan Ubaldo Robles-Flores, Amelia Rodríguez-Trejo, Efraín Salas-Gonzáles, Juan Alejandro Silva, Gilberto Solorza-Luna, Rosalía Souto-del-Bosque, Laura Leticia Tirado-Gómez, Salvador Torrescano-González, Alfonso Torres-Lobatón, Elizabeth Trejo-Durán, Verónica Villavicencio-Valencia, Dolores Gallardo-Rincón
INTRODUCTION: Endometrial cancer (EC) is the second most common gynecologic malignancy worldwide in the peri and postmenopausal period. Most often for the endometrioid variety. In early clinical stages long-term survival is greater than 80%, while in advanced stages it is less than 50%. In our country there is not a standard management between institutions. GICOM collaborative group under the auspice of different institutions have made the following consensus in order to make recommendations for the management of patients with this type of neoplasm...
November 2010: Revista de Investigación Clínica; Organo del Hospital de Enfermedades de la Nutrición
https://www.readbyqxmd.com/read/18838886/a-phase-ii-trial-of-fixed-dosed-rate-gemcitabine-in-platinum-resistant-ovarian-cancer-a-geico-grupo-espa%C3%A3-ol-de-investigaci%C3%A3-n-en-c%C3%A3-ncer-de-ovario-trial
#5
Belen Ojeda Gonzalez, Antonio Gonzalez Martin, Isabel Bover Barcelo, Xavier Fabregat i Mayol, Begoña Mellado, María Jesus Rubio Perez, Lorenzo Alonso Carrion, Antonio Casado Herraez, Elisa Calvo Garcia, Cristina Churruca Galaz, Angels Arcusa Lanza, Ana Herrero Ibañez, Encarna Adrover Cebrian, Andres Poveda Velasco
OBJECTIVES: Gemcitabine has well-recognized activity in the treatment of ovarian cancer. Fixed-dose rate (FDR) delivery has been proposed as a more rationale way to administer gemcitabine, to avoid saturation of the enzyme that catalyzes its intracellular transformation into the active metabolites, difluorodeoxycitidine biphosphate, and triphosphate. Our aim was to assess clinical activity of gemcitabine delivered by FDR infusion in patients with platinum resistant ovarian cancer. MATERIALS AND METHODS: Patients with platinum-resistant ovarian cancer received gemcitabine 1000 mg/m(2) over 120 minutes on days 1 and 8 of each cycle...
October 2008: American Journal of Clinical Oncology
https://www.readbyqxmd.com/read/18336404/ten-years-of-optimal-therapy-in-advanced-ovarian-cancer-update-meeting
#6
A Poveda
The International Symposium on Advanced Ovarian Cancer: Optimal Therapy was founded by Dr. Andrés Poveda and Prof. Jan B. Vermorken, and each edition has been directed by them. The 6th edition was held on March 2, 2007. This symposium is organized every other year by GEICO (Grupo Español de Investigación de Cáncer de Ovario/Spanish Ovarian Cancer Research Group), under the auspices of the Spanish Society of Medical Oncology (SEOM), the Gynecologic Cancer Intergroup (GCIG), and the European Society of Medical Oncology (ESMO) Educational Committee for its Medical Oncology Recertification Approval (ESMO/MORA) Program...
March 2008: International Journal of Gynecological Cancer
https://www.readbyqxmd.com/read/15817604/randomized-phase-ii-trial-of-carboplatin-versus-paclitaxel-and-carboplatin-in-platinum-sensitive-recurrent-advanced-ovarian-carcinoma-a-geico-grupo-espanol-de-investigacion-en-cancer-de-ovario-study
#7
RANDOMIZED CONTROLLED TRIAL
A J González-Martín, E Calvo, I Bover, M J Rubio, A Arcusa, A Casado, B Ojeda, C Balañá, E Martínez, A Herrero, B Pardo, E Adrover, J Rifá, M J Godes, A Moyano, A Cervantes
BACKGROUND: The aim of this study was to determine whether the response rate for the paclitaxel-carboplatin combination is superior to carboplatin alone in the treatment of patients with platinum-sensitive recurrent ovarian carcinoma. PATIENTS AND METHODS: Patients with recurrent ovarian carcinoma, 6 months after treatment with a platinum-based regimen and with no more than two previous chemotherapy lines, were randomized to receive carboplatin area under the curve (AUC) 5 (arm A) or paclitaxel 175 mg/m(2) + carboplatin AUC 5 (arm B)...
May 2005: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://www.readbyqxmd.com/read/13805877/-recent-observations-on-remote-radiological-behavior-of-pleuro-pulmonary-and-skeletal-metastases-in-breast-cancer-following-bilateral-ovario-adrenalectomy
#8
https://www.readbyqxmd.com/read/13496312/-evaluation-of-estrogen-activity-in-breast-cancer-after-ovario-adrenalectomy-preliminary-note
#9
R GRATTAROLA, V CATANIA
No abstract text is available yet for this article.
July 1957: Tumori
https://www.readbyqxmd.com/read/13325001/-bilateral-ovario-adrenalectomy-for-incurable-breast-cancer-and-its-metastases-clinical-data-on-12-cases
#10
P BUCALOSSI, V C CATANIA, S DI PIETRO, A SOMIGLI
No abstract text is available yet for this article.
January 1956: Tumori
https://www.readbyqxmd.com/read/5598335/-ovario-endometrial-and-adrenal-endometrial-synergism-in-relation-to-the-treatment-of-breast-cancer
#11
M Pérez Carreño
No abstract text is available yet for this article.
1967: Acta Científica Venezolana
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"